Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

Similar articles for PubMed (Select 24440092)

1.

Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.

Liau JY, Liao SL, Hsiao CH, Lin MC, Chang HC, Kuo KT.

Hum Pathol. 2014 Mar;45(3):533-9. doi: 10.1016/j.humpath.2013.10.019. Epub 2013 Oct 30.

PMID:
24440092
2.

Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome.

Holbach LM, von Moller A, Decker C, Jünemann AG, Rummelt-Hofmann C, Ballhausen WG.

Am J Ophthalmol. 2002 Jul;134(1):147-8.

PMID:
12095833
3.

Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.

Attaleb M, El hamadani W, Khyatti M, Benbacer L, Benchekroun N, Benider A, Amrani M, El Mzibri M.

Oncol Res. 2009;18(4):185-92.

PMID:
20112504
4.

DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.

Rajan Kd A, Burris C, Iliff N, Grant M, Eshleman JR, Eberhart CG.

Am J Ophthalmol. 2014 Mar;157(3):640-7.e1-2. doi: 10.1016/j.ajo.2013.12.002. Epub 2013 Dec 7.

PMID:
24321472
5.

Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.

Ivanova TA, Golovina DA, Zavalishina LE, Volgareva GM, Katargin AN, Andreeva YY, Frank GA, Kisseljov FL, Kisseljova NP.

BMC Cancer. 2007 Mar 14;7:47.

6.

Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients.

Goldberg M, Rummelt C, Foja S, Holbach LM, Ballhausen WG.

Hum Mutat. 2006 Feb;27(2):155-62.

PMID:
16395674
7.

Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia.

Ishikawa M, Fujii T, Saito M, Nindl I, Ono A, Kubushiro K, Tsukazaki K, Mukai M, Nozawa S.

Int J Gynecol Cancer. 2006 Jan-Feb;16(1):347-53.

PMID:
16445657
8.

P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix.

Masumoto N, Fujii T, Ishikawa M, Saito M, Iwata T, Fukuchi T, Susumu N, Mukai M, Kubushiro K, Tsukazaki K, Nozawa S.

Hum Pathol. 2003 Aug;34(8):778-83.

PMID:
14506638
9.

The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome.

Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH, Lin MC.

Mod Pathol. 2008 Apr;21(4):376-86. doi: 10.1038/modpathol.3800979. Epub 2008 Jan 25.

10.

Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.

Terra AP, Murta EF, Maluf PJ, Caballero OL, Brait M, Adad SJ.

Tumori. 2007 Nov-Dec;93(6):572-9.

PMID:
18338492
11.

Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.

Jayaraj P, Sen S, Sharma A, Chosdol K, Kashyap S, Rai A, Pushker N, Bajaj MS, Ghose S.

Br J Dermatol. 2012 Sep;167(3):583-90. doi: 10.1111/j.1365-2133.2012.10968.x. Epub 2012 Jul 19.

PMID:
22458737
12.

Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.

Kanao H, Enomoto T, Ueda Y, Fujita M, Nakashima R, Ueno Y, Miyatake T, Yoshizaki T, Buzard GS, Kimura T, Yoshino K, Murata Y.

Cancer Lett. 2004 Sep 15;213(1):31-7.

PMID:
15312681
13.

The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.

Cohen Y, Singer G, Lavie O, Dong SM, Beller U, Sidransky D.

Clin Cancer Res. 2003 Aug 1;9(8):2981-4.

14.

Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort.

de Freitas Cordeiro-Silva M, Stur E, Agostini LP, de Podestá JR, de Oliveira JC, Soares MS, Mendonça EF, Gouvea SA, Von Zeidler SV, Louro ID.

Mol Biol Rep. 2012 Dec;39(12):10111-9. doi: 10.1007/s11033-012-1885-4. Epub 2012 Aug 31.

PMID:
22936053
16.

Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx.

Chernock RD, Wang X, Gao G, Lewis JS Jr, Zhang Q, Thorstad WL, El-Mofty SK.

Mod Pathol. 2013 Feb;26(2):223-31. doi: 10.1038/modpathol.2012.159. Epub 2012 Sep 21.

17.

Promoter methylation of p16(INK4A), hMLH1, and MGMT in liquid-based cervical cytology samples compared with clinicopathological findings and HPV presence.

Spathis A, Aga E, Alepaki M, Chranioti A, Meristoudis C, Panayiotides I, Kassanos D, Karakitsos P.

Infect Dis Obstet Gynecol. 2011;2011:927861. doi: 10.1155/2011/927861. Epub 2011 Jun 4.

18.

Sebaceous carcinoma. Tumor progression through mutational inactivation of p53.

Gonzalez-Fernandez F, Kaltreider SA, Patnaik BD, Retief JD, Bao Y, Newman S, Stoler MH, Levine PA.

Ophthalmology. 1998 Mar;105(3):497-506.

PMID:
9499782
19.

Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection.

Steinestel J, Cronauer MV, Müller J, Al Ghazal A, Skowronek P, Arndt A, Kraft K, Schrader M, Schrader AJ, Steinestel K.

PLoS One. 2013 May 28;8(5):e65189. doi: 10.1371/journal.pone.0065189. Print 2013.

20.

CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.

Bradly DP, Gattuso P, Pool M, Basu S, Liptay M, Bonomi P, Buckingham L.

Diagn Mol Pathol. 2012 Dec;21(4):207-13. doi: 10.1097/PDM.0b013e31825554b2.

PMID:
23111194
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk